Impact of Small Tumor Size on Prognosis in T3N1 Colon Cancer

被引:0
|
作者
Tamai, Koki [1 ]
Tei, Mitsuyoshi [1 ]
Tsujimura, Naoto [1 ]
Nishida, Kentaro [1 ]
Mori, Soichiro [1 ]
Yoshikawa, Yukihiro [1 ]
Nomura, Masatoshi [1 ]
Hamakawa, Takuya [1 ]
Takiuchi, Daisuke [1 ]
Tsujie, Masanori [1 ]
Akamaru, Yusuke [1 ]
机构
[1] Osaka Rosai Hosp, Dept Gastroenterol Surg, Sakai, Japan
关键词
colon cancer; prognosis; tumor size; COLORECTAL-CANCER; ADJUVANT CHEMOTHERAPY; MULTIVARIATE-ANALYSIS; SURVIVAL; EPIDEMIOLOGY; ASSOCIATION; POPULATION; GUIDELINES; RESECTION; PREDICT;
D O I
10.1002/wjs.12480
中图分类号
R61 [外科手术学];
学科分类号
摘要
BackgroundTraditionally, large tumor size is associated with poor survival in colon cancer, but its impact remains limited and controversial. Recently, the impact of small tumor size on prognosis has gained attention. This study aimed to investigate whether small tumor size can be an additional parameter for T3N1 colon cancer prognosis. MethodsWe retrospectively analyzed 162 consecutive patients with pT3N1 colon cancer between 2010 and 2021. The optimal cutoff value of tumor size was calculated through receiver operating characteristic curve analysis. We evaluated survival through the Kaplan-Meier method, and the risk of prognosis through multivariate Cox models. ResultsThe optimal cutoff value of tumor size was 45 mm. The recurrence rate was significantly higher in tumor size < 45 mm than in >= 45 mm (25.7% vs. 12.0%, p = 0.037). Tumor size < 45 mm also had lower overall survival (OS), recurrence-free survival (RFS), and cancer-specific survival (CSS) than its counterpart (p = 0.03 for all). In multivariate analyses, age >= 70 years, undifferentiated histological type, and tumor size < 45 mm were independent prognostic factors for OS (p = 0.025, p = 0.001, p < 0.04, respectively), whereas tumor size < 45 mm was the only independent prognostic factor for RFS (p = 0.043). Meanwhile, the independent prognostic factors for CSS were undifferentiated histological type and tumor size < 45 mm (p = 0.008 for both). ConclusionsSmall tumor size is associated with poor prognosis in pT3N1 colon cancer cases. Thus, small tumors potentially have biologically aggressive features.
引用
收藏
页码:343 / 352
页数:10
相关论文
共 50 条
  • [41] The role of PEG3 in the occurrence and prognosis of colon cancer
    Zhou, Ting
    Lin, Wei
    Zhu, Qiongni
    Renaud, Helen
    Liu, Xiaowei
    Li, Ruidong
    Tang, Cui
    Ma, Chong
    Rao, Tai
    Tan, Zhirong
    Guo, Ying
    ONCOTARGETS AND THERAPY, 2019, 12 : 6001 - 6012
  • [42] Clinical significance of invasion distance relative to prognosis in pathological T3 colorectal cancer
    Nomura, Masatoshi
    Takahashi, Hidekazu
    Fujii, Makoto
    Miyoshi, Norikatsu
    Haraguchi, Naotsugu
    Hata, Taishi
    Matsuda, Chu
    Yamamoto, Hirofumi
    Mizushima, Tsunekazu
    Mori, Masaki
    Doki, Yuichiro
    ONCOLOGY LETTERS, 2019, 18 (05) : 5614 - 5620
  • [43] Elevated tumor expression of Astroprincin (FAM171A1) is an independent marker of poor prognosis in colon cancer
    Kaprio, Tuomas
    Lindstrom, Alexander M.
    Rasila, Tiina
    Saavalainen, Olga
    Beilmann-Lehtonen, Ines
    Mustonen, Harri
    Haglund, Caj
    Andersson, Leif C.
    BMC GASTROENTEROLOGY, 2021, 21 (01)
  • [44] Smaller tumor size is associated with poor survival in stage II colon cancer: An analysis of 7,719 patients in the SEER database
    Huang, Ben
    Feng, Yang
    Zhu, Liang
    Xu, Tianhong
    Huang, Liyong
    Cai, Guoxiang
    INTERNATIONAL JOURNAL OF SURGERY, 2016, 33 : 157 - 163
  • [45] Identification of signature of tumor-infiltrating CD8 T lymphocytes in prognosis and immunotherapy of colon cancer by machine learning
    Liao, Kaili
    Yang, Qijun
    Xu, Yuhan
    He, Yingcheng
    Wang, Jingyi
    Li, Zimeng
    Wu, Chengfeng
    Hu, Jialing
    Wang, Xiaozhong
    CLINICAL IMMUNOLOGY, 2023, 257
  • [46] Low tumor purity is associated with poor prognosis, heavy mutation burden, and intense immune phenotype in colon cancer
    Mao, Yihao
    Feng, Qingyang
    Zheng, Peng
    Yang, Liangliang
    Liu, Tianyu
    Xu, Yuqiu
    Zhu, Dexiang
    Chang, Wenju
    Ji, Meiling
    Ren, Li
    Wei, Ye
    He, Guodong
    Xu, Jianmin
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 3569 - 3577
  • [47] Effect of Tumor Size on Prognosis in Patients Treated with Radical Radiotherapy or Chemoradiotherapy for Non-Small Cell Lung Cancer
    Ball, David
    Mitchell, Alan
    Giroux, Dori
    Rami-Porta, Ramon
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (03) : 315 - 321
  • [48] Tumor size measured by multidetector CT in resectable colon cancer: correlation with regional lymph node metastasis and N stage
    Mou, Anna
    Li, Hang
    Chen, Xiao-li
    Fan, Yang-hua
    Pu, Hong
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2021, 19 (01)
  • [49] Low levels of BRCA1 protein expression predict a worse prognosis in stage I-II colon cancer
    Du, Changzheng
    Peng, Yifan
    He, Yiping
    Chen, Guoan
    Chen, Hao
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2021, 36 (01) : 47 - 53
  • [50] Nomograms predicting prognosis of patients with pathological stages T1N2-3 and T3N0 gastric cancer
    Wang, Yu-Fei
    Yin, Xin
    Fang, Tian-Yi
    Wang, Yi-Min
    Zhang, Dao-Xu
    Zhang, Yao
    Wang, Xi-Bo
    Wang, Hao
    Xue, Ying-Wei
    WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2022, 14 (02): : 143 - 160